Renal Cancer
A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of a HC-7366 in Combination with Belzutifan (WeliregTM) in Patients with Locally Advanced or Metastatic Renal Cell Carcinoma (HC366-RCC2311 / MK-6482-030)
- Details
ClinicalTrials.gov ID:
NCT06234605
Diagnosis Type:
NA
USOR Number:
- Address
,
P: